Stephensonmurphy8993

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults. The introduction of novel oral agents, starting with ibrutinib in 2013, has revolutionized the therapeutic landscape; however, clinical trials have suggested an association between ibrutinib and the risk of bleeding-related adverse events and atrial fibrillation (Afib) in patients with CLL.

Patients diagnosed and treated for CLL at the Veterans Health Administration (VHA) from 2010 to 2014 were followed until December 31, 2016, death, or lack of utilization of hematology/oncology services for ≥ 18 months; or until incidence of another cancer. Treatments dispensed, evidence of VHA system use, bleeding events, and Afib were determined from the administrative records, laboratory records, pharmacy dispensation records, and clinical notes in the electronic healthcare record.

From 2010 to 2014, 2,796 patients were diagnosed and received care for CLL within the VHA, of whom 172 patients received ibrutinib and 291 received bendamue to those reported in previous clinical trials. These findings suggest that patients in real-world clinical care settings with higher levels of comorbidities may be at an increased risk for bleeding events and Afib.

Radiotherapy plays an important role in the palliation of lung cancer, which is the second most common cancer diagnosed in the Veterans Health Administration (VHA). The American Society for Radiation Oncology (ASTRO) developed evidenced-based treatment guidelines for the management of patients with metastatic lung cancer.

In May 2016, an electronic survey of 88 VHA radiation oncologists (ROs) was conducted to assess metastatic lung cancer management. Demographic information was obtained and 2 clinical scenarios were presented to glean opinions on dose/fractionation schemes preferred, preferences for/against concurrent chemotherapy, and use of endobronchial brachytherapy (EBB) and/or yttrium aluminum garnet (YAG) laser technology. Survey results were assessed for concordance with published ASTRO guidelines.

The survey response rate was 61%, with 93% of the 40 VHA radiation departments represented. Among respondents, 96% were board certified, and 90% held academic appointments. 88% were familiar with ASTRO guidelines. Preferred fractionation schemes were 20 Gy in 5 fractions (69%) and 30 Gy in 10 fractions (22%). The vast majority (98%) did not recommend concurrent chemotherapy for palliation. In the setting of bronchial obstruction with lung collapse, about half (49%) recommended EBB or YAG lung reexpansion before external beam radiotherapy. Selleck Glesatinib A minority of respondents use stereotactic body radiotherapy or EBB for palliation.

Most respondents demonstrated up-to-date knowledge of current evidence-based treatment guidelines. We found no distinction in clinical decisions based on demographic profiles.

Most respondents demonstrated up-to-date knowledge of current evidence-based treatment guidelines. We found no distinction in clinical decisions based on demographic profiles.

Chest imaging often incidentally finds indeterminate nodules that need to be monitored to ensure early detection of lung cancers. Health care systems need effective approaches for identifying these lung nodules. We compared the diagnostic performance of 2 approaches for identifying patients with lung nodules on imaging studies (chest/abdomen) (1) relying on radiologists to code imaging studies with lung nodules; and (2) applying a text search algorithm to identify references to lung nodules in radiology reports.

We assessed all radiology studies performed between January 1, 2016 and November 30, 2016 in a single Veterans Health Administration hospital. We first identified imaging reports with a diagnostic code for a pulmonary nodule. We then applied a text search algorithm to identify imaging reports with key words associated with lung nodules. We reviewed medical records for all patients with a suspicious radiology report based on either search strategy to confirm the presence of a lung nodule. We calculimportant nodules.

The text search algorithm can identify additional patients with lung nodules compared to the radiology coding; however, this strategy requires substantial clinical review time to confirm nodules. Health care systems adopting nodule-tracking approaches should recognize that relying only on radiology coding might miss clinically important nodules.

Low dose, low-resolution computed tomography (CT) is used for attenuation correction to improve the quality of single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). Because of its low resolution, these CT images are considered non-diagnostic and are not routinely or uniformly reviewed or interpreted by a cardiologist. On the other hand, low-dose CT has been used for lung cancer screening to reduce lung cancer mortality and is recommended for annual screening of high-risk patients by the US Preventive Services Task Force.

Siemens Symbia Intevo Excel SPECT/CT scanners, used primarily for cardiac MPI, were used in the study. The study was intended to report incidental findings of pulmonary and hilar malignancy detected by these CT images during cardiac evaluation. It included 1,098 consecutive patients who had SPECT MPI from September 1, 2017 to August 31, 2018. When suspicious pulmonary nodules or abnormalities were identified, primary care providers were notified of the findings and recommendations for further evaluation.

Five patients were found to have lung cancer (all male with substantial smoking history, aged 64-75 years), 1 had mantle cell lymphoma. Six of 1,098 (0.55%) patients were found to have incidental pulmonary/hilar malignancy, which is comparable to the yield (0.65%/year) of detecting lung cancer using low-dose CT for screening in The National Lung Screening Trial.

Routine review and report of incidental findings on low-resolution CT during cardiac MPI by physicians skilled in CT interpretation is necessary to identify incidental but clinically important findings, including malignancies.

Routine review and report of incidental findings on low-resolution CT during cardiac MPI by physicians skilled in CT interpretation is necessary to identify incidental but clinically important findings, including malignancies.